A Study of Low and Standard-dose Ticagrelor After Intervention for ACS Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 2120 participants.
Also called NCT04255602
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 2,120 participants
- Registry
-
NCT04255602
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04255602. Randomized; no masking; primary purpose treatment. Start 2020-02-19 (actual); primary completion 2024-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of Low and Standard-dose Ticagrelor After Intervention for ACS Patients
- Acronym
- TIGER
- Condition
- Acute Coronary Syndrome
- Condition
- Coronary Stent Implantation
- Intervention (Drug)
- Ticagrelor 60mg
- Intervention (Drug)
- Ticagrelor 90mg
- Lead sponsor
- Shanghai Tong Ren Hospital
- Collaborator
- Shanghai Jiao Tong University School of Medicine
- Collaborator
- Fudan University
Record details
- Record id
cardio:ct-nct04255602- Content hash
4e6aee11f7d2ce677a8ea4e47a2975e5f7df59cd86638b4a62d0a63754ffb3c2